Taken together, our results revealed a tumor-promoting role of IKK/NF-κB signaling in SCLC, in line with previous studies showing that NF-κB critically contributes to Kras mutation-driven lung adenocarcinoma [25–27]. The gene discussed is NFKB1; the disease is lung adenocarcinoma.